Business
New patent grants
New patent grants.
About this update from Directa Plus Plc
[{"type":"text","content":"\n \nRNS Number : 9202Z Directa Plus PLC 23 May 2019 \n\n23 May 2019\n \nDirecta Plus plc\n(\"Directa Plus\" or the \"Company\")\n \nNew patent grants\n \nDirecta Plus (AIM: DCTA), a leading producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce that the Company has been granted two new patents, for the application of the Company's G+ graphene products.\n \nGraphene enhanced golf balls\n \nThe first is an Italian patent for the use of the Company's G+ graphene in the manufacture of golf balls. The use of the G+ compounds in golf balls, can provide a series of beneficial features that offer opportunities to develop a new generation of golf ball, both for professional and amateur players.\n \nCertain G+ compounds will be able to achieve particular qualities when added to golf balls.\n \nG+ materials can be used to enhance the hard core of professional golf balls in order to increase the shot distance potential of the ball, without losing lateral control. In addition, G+ can be used in the amateur golf ball market, to guarantee swing and improved control.\n \nPreparing Graphene Nanoplatelets\n \nThe second is a Chinese patent, covering Directa Plus' unique process for the manufacturing graphene nanoplatelets.\nDirecta Plus's unique exfoliation technology is chemical free, has an extremely high yield, and can be varied to produce graphene nanoplatelets with specific morphologies. This means that G+ products are safe for human health, can be tailor-made to meet customers' needs, and the high-yields create competitive prices.\nAdditionally, the unique characteristics of the G+ process, allow the Company to enter large supply chains, in turn overcoming important entry barriers into the market.\n \nCommenting on the agreement, Giulio Cesareo, Founder and CEO of Directa Plus, said:\n \n\"I'm very pleased that we were able to secure two new patents. We continue to show how our G+ graphene nanoplatelets can enhance products in various categories, and it is vital that we secure the Intellectual Property rights needed to protect our unique technology in worldwide jurisdictions.\n \n\"Securing Intellectual Property rights for our technological innovations is a key part of our corporate strategy - across global jurisdi...